Mylan will host a conference a call and live webcast today, February 27, 2008 at 5:00 p.m. ET, in conjunction with the release of its financial results. The dial-in number to access the call is 877-874-1586 or 719-325- 4814 for international callers. A replay, available for approximately eight days, will be available at 888-203-1112 or 719-457-0820 for international callers, with access pass code 8774583. The live webcast and replay, which will be available for approximately eight days, is accessible at http://www.mylan.com.
Mylan Inc. is one of the world's leading quality generic and specialty
pharmaceutical companies. The Company offers one of the industry's broadest
and highest quality product portfolios, a robust product pipeline and a
global commercial footprint through operations in more than 90 countries.
Through its controlling interest in Matrix Laboratories Limited, Mylan has
direct access to one of the largest active pharmaceutical ingredient (API)
manufacturers in the world. Dey L.P., Mylan's fully integrated specialty
business, provides the Company with innovative and diversified
opportunities in the respiratory and allergy therapeutic areas.
Mylan Inc. and Subsidiaries
Condensed Consolidated Statements of Earnings
(unaudited; in thousands, except per share amounts)
Three Months Ended Nine Months Ended
December 31, December 31, December 31, December 31,
2007 2006 2007 2006
Net revenues $1,147,834 $396,692 $2,162,943 $1,103,247
Other revenues 7,515 5,069 15,818 21,310
Total revenues 1,155,349 401,761 2,178,761 1,124,557
Cost of sale
|SOURCE Mylan Inc.|
Copyright©2008 PR Newswire.
All rights reserved